Well Referenced

Tag: Nicotinamide riboside

Nicotinamide adenine dinucleotide is transported into mammalian mitochondria

This study provides evidence that mammalian mitochondria import intact NAD⁺, challenging the long-held belief that the mitochondrial inner membrane is impermeable to pyridine nucleotides. Using isotopically labeled nicotinamide riboside and nicotinic acid riboside, the researchers demonstrated that labeled NAD⁺ appears within mitochondria, indicating direct import rather than synthesis from precursors

Read More »
June 26, 2025 No Comments

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

This 2016 study evaluated the pharmacokinetics and bioavailability of nicotinamide riboside (NR), a vitamin B3 derivative, in both mice and humans. In mice, oral NR administration led to significant increases in hepatic NAD⁺ levels, outperforming other NAD⁺ precursors like nicotinic acid and nicotinamide. In a human pilot study, a single

Read More »
June 26, 2025 No Comments

NAD⁺ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis

This 2021 review explores the therapeutic potential of combining NAD⁺ precursors, such as nicotinamide riboside (NR), with antioxidants like pterostilbene in treating amyotrophic lateral sclerosis (ALS). The study highlights how oxidative stress and disrupted NAD⁺ metabolism contribute to motor neuron degeneration in ALS. By enhancing NAD⁺ levels and activating pathways

Read More »
June 26, 2025 No Comments

Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors

This 2021 review examines the pharmacological properties and therapeutic potential of NAD⁺ precursors, including nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and nicotinic acid (NA). The authors discuss how these compounds enhance NAD⁺ levels, influencing cellular redox states, energy metabolism, and sirtuin activity. The review highlights the role of NAD⁺ in

Read More »
June 26, 2025 No Comments

Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration After Axotomy

This 2006 study investigates the role of NAD⁺ biosynthesis in axonal protection following injury. Researchers overexpressed various NAD⁺ biosynthetic enzymes and administered their respective substrates in cultured dorsal root ganglion (DRG) neurons. Among the enzymes tested, NMNAT1 exhibited the strongest protective effect against axonal degeneration, while NMNAT3 and a cytoplasm-localized

Read More »
June 26, 2025 No Comments

A Decrease in NAD⁺ Contributes to the Loss of Osteoprogenitors and Bone Mass with Aging

This 2021 study explores how declining NAD⁺ levels in osteoblast progenitor cells contribute to age-related bone loss. Researchers found that aged mice exhibited reduced NAD⁺ levels in osteoprogenitors, leading to increased acetylation of FoxO1 and β-catenin, markers of cellular senescence, and diminished osteoblastogenesis. Supplementation with the NAD⁺ precursor nicotinamide riboside

Read More »
June 26, 2025 No Comments

NAD⁺ Boosting Reduces Age-Associated Amyloidosis and Restores Mitochondrial Homeostasis in Muscle

This 2021 study investigates the impact of NAD⁺ boosting on age-related muscle degeneration. The research demonstrates that aging is associated with the accumulation of amyloid-like deposits and mitochondrial dysfunction in muscle tissues across species, including C. elegans, mice, and humans. Treatment with NAD⁺ precursors, such as nicotinamide riboside (NR) and

Read More »
June 26, 2025 No Comments

NAD⁺ Repletion Reverses Heart Failure With Preserved Ejection Fraction

This 2021 study demonstrates that NAD⁺ repletion can reverse heart failure with preserved ejection fraction (HFpEF) in a mouse model. Researchers found that HFpEF is associated with reduced myocardial NAD⁺ levels, leading to mitochondrial protein hyperacetylation and impaired fatty acid oxidation. Supplementation with NAD⁺ precursors, such as nicotinamide riboside (NR)

Read More »
June 26, 2025 No Comments

NAD+ in Aging: Molecular Mechanisms and Translational Implications

This 2017 review explores the critical role of nicotinamide adenine dinucleotide (NAD⁺) in aging and age-related diseases. NAD⁺ is essential for cellular metabolism, DNA repair, and stress responses. The study highlights that NAD⁺ levels decline with age, contributing to various pathologies, including neurodegenerative diseases, cardiovascular conditions, and muscle atrophy. The

Read More »
June 26, 2025 No Comments

Vitamins and aging: pathways to NAD+ synthesis

This 2007 commentary highlights the discovery of nicotinamide riboside (NR) as a novel NAD+ precursor that enhances Sir2 deacetylase activity and extends lifespan in yeast. NR operates through the Nrk and Urh1/Pnp1/Meu1 pathways, offering an alternative to the classical Preiss-Handler and salvage pathways for NAD+ synthesis. The findings suggest that

Read More »
June 26, 2025 No Comments